LONDON, England, Sept. 14 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 17, No. 27 edition:

Clinical Trial Protocol:

* Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies

Short Communications:

* Deregulation of mitochondrial sirtuins and OGG1-2a acts as a prognostic and dia . . .

Click here for more information about our products